Michael David Smith - Net Worth and Insider Trading

Michael David Smith Net Worth

The estimated net worth of Michael David Smith is at least $0 dollars as of 2025-07-23. Michael David Smith is the Senior VP, Development of KalVista Pharmaceuticals Inc and owns about 0 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $0. Details can be seen in Michael David Smith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael David Smith has not made any transactions after 2021-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Michael David Smith

To

Michael David Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael David Smith owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .

Click here to see the complete history of Michael David Smith’s form 4 insider trades.

Insider Ownership Summary of Michael David Smith

Ticker Company Transaction Date Type of Owner
KALV KalVista Pharmaceuticals Inc 2021-06-01 Senior VP & Development

Michael David Smith Latest Holdings Summary

Michael David Smith currently owns a total of 1 stock. Michael David Smith owns 0 shares of KalVista Pharmaceuticals Inc (KALV) as of June 1, 2021, with a value of $0.

Latest Holdings of Michael David Smith

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KALV KalVista Pharmaceuticals Inc 2021-06-01 0 15.81 0

Holding Weightings of Michael David Smith


Michael David Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael David Smith has made a total of 2 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 7,500 shares on June 1, 2021, which brought Michael David Smith around $201,225.

Insider Trading History of Michael David Smith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael David Smith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael David Smith Ownership Network

Ownership Network List of Michael David Smith

No Data

Ownership Network Relation of Michael David Smith

Insider Network Chart


Michael David Smith Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Michael David Smith is the Senior VP & Development of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Development Officer Christopher Yea , and Chief Medical Officer Paul K. Audhya .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Michael David Smith made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net sale of 202,403 shares made by Benjamin L Palleiko , a net sale of 123,334 shares made by Christopher Yea , and a net sale of 60,972 shares made by Paul K. Audhya .

In summary, during the past 3 months, insiders sold 98,659 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 98,659 shares. During the past 18 months, 544,500 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 726,292 shares were bought by its insiders, resulting in a net purchase of 181,792 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

Michael David Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Michael David Smith. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael David Smith's mailing address is: Cambridge Ma 02142.